Amniotic stem cells show promise in helping to repair cardiac birth defects

October 9, 2013, American College of Surgeons

Researchers at the University of Michigan Department of Surgery have begun testing an alternative to embryonic stem cells that could one day regenerate muscle tissue for babies with congenital heart defects. A research-in-progress report on this new approach, which uses amniotic stem cells, was presented today at the 2013 Clinical Congress of the American College of Surgeons. Although this research is still in an early phase, this new approach has the potential to one day help thousands of babies born each year with congenital heart defects.

Typically, a pregnant woman can have a fetal ultrasound performed to find out the sex of her baby between 18 and 20 weeks gestation. But each year during pregnancy or after birth, 40,000 women also find out that their babies have birth defects in their hearts, according to the Centers for Disease Control and Prevention.*

Babies with congenital defects often go through multiple heart operations or even a transplant before their first birthday. But Shaun Kunisaki, MD, a pediatric surgeon and assistant professor of surgery at the University of Michigan, and his surgical team are testing a new method of regenerating defective heart tissue so that one day these multiple operations may no longer be necessary.

"We know that the baby's heart are functioning, but the muscle has developed abnormally," lead study author Dr. Kunisaki said. "We have to find the right source of new cells to replace the damaged cells or generate new tissue to augment the damaged heart."

Stem Cell Shortfalls

Until now have shown potential to morph into various types of organ tissues, but the ethics surrounding the process of having to destroy the embryo to achieve this outcome has drawn controversy.

Stem cells from have also seemed promising, but such cells are obviously hard to obtain from a fetus. Furthermore, getting bone marrow from a donor brings about the same risk as having a heart transplant—having to suppress the newborn infant's immune system so that its body doesn't reject the foreign cells. "Also, bone marrow cells are not made to function like , but rather to protect against inflammation," Dr. Kunisaki explained.

Cardiac stem cells, which are in the heart, have also been considered, but the heart contains a very limited number of these stem cells.

Amniotic stem cells, however, contain the same genetic makeup as the fetus. Therefore, this approach eliminates the possibility of the newborn infant's body rejecting the cells. And these cells are easily obtainable from amniocentesis, a standard prenatal genetic test in which fluid is extracted from the amniotic sac.

Morphing into heart muscle cells

Beginning in the last quarter of 2011, Dr. Kunisaki and his team obtained amniotic fluid samples from eight pregnant women. They extracted a type of cell called mesenchymal stromal cells, which are the most common type of cell in amniotic fluid.

The next step was to transform those cells into induced with the exact genetic makeup of the fetus. This step involved genetically reprogramming the cells to be, similar to embryonic stem cells, flexible enough to morph into any cell in the human body—such as the heart muscle.

"Once you have true stem cells, then you can expose these cells in a culture condition, which favors transformation into a heart cell," Dr. Kunisaki reported.

After three weeks in a culture, Dr. Kunisaki and his team observed the amniotic stem cells transform into heart muscle cells. The team confirmed that the cells were indeed with an antibody test, which has signature proteins that only bind to certain types of cells—in this case, the newly grown heart cells. "And you could see these cells beating in the culture dish," he added.

Next steps and ultimate goals

In the future, Dr. Kunisaki envisions being able to deliver amniotic stem cells to babies with soon after delivery. The cells would then begin to regenerate damaged tissue into a healthy heart or could serve to augment heart operations. This treatment could help newborn infants stay alive without a transplant.

"Babies have to rely on mom and the placenta for everything. After they're born, they have to rely on their own hearts to function," Dr. Kunisaki explained. "The ideal situation is to have heart available when they are born. We diagnose at about 20 weeks gestation. That timeframe gives five months or so to generate heart cells to use at birth."

The researchers' laboratory process of transforming into beating heart cells took just under 12 weeks. The next step is to move the study to a mouse model, which Dr. Kunisaki estimates will begin in 2014. The ultimate step will be testing the procedure on an actual baby.

"Pregnancy is supposed to be a time to celebrate and welcome a new family member into the world. One of the hardest parts of my job as a surgeon is telling a family that their baby has a heart defect," Dr. Kunisaki said. "Instead, these families have to talk about unforeseen circumstances, such as how to care for a seriously ill child after birth. Often there are not many comforting answers, but our goal is to offer more options."

Explore further: Study shows amniotic fluid stem cells, heart cells pass signals without touching

More information: * Centers for Disease Control and Prevention. Congenital Heart Defects – Data and Statistics. Available at: www.cdc.gov/ncbddd/heartdefects/data.html. Accessed September 6, 2013.

Related Stories

Study shows amniotic fluid stem cells, heart cells pass signals without touching

May 2, 2013
Stem cells drawn from amniotic fluid show promise for tissue engineering, but it's important to know what they can and cannot do. A new study by researchers at Rice University and Texas Children's Hospital has shown that ...

Mayo Clinic first in US to test stem cells in pediatric congenital heart disease patients

June 11, 2013
Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic ...

Heart's own stem cells offer hope for new treatment of heart failure

August 15, 2013
Researchers at King's College London have for the first time highlighted the natural regenerative capacity of a group of stem cells that reside in the heart. This new study shows that these cells are responsible for repairing ...

Mayo Clinic restores disrupted heartbeat with regenerative intervention

September 3, 2013
Mayo Clinic researchers have found a way to resynchronize cardiac motion following a heart attack using stem cells. Scientists implanted engineered stem cells, also known as induced pluripotent stem (iPS) cells, into damaged ...

Scientists identify key regulator controlling formation of blood-forming stem cells

September 26, 2013
Stem cell scientists have moved one step closer to producing blood-forming stem cells in a Petri dish by identifying a key regulator controlling their formation in the early embryo, shows research published online today in ...

Molecular beacons light path to cardiac muscle repair

September 5, 2013
Pure cardiac muscle cells, ready to transplant into a patient affected by heart disease.

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.